PT Medela Potentia Tbk (ISX:MDLA) Research & Development: Rp0 Mil (TTM As of Mar. 2026)


ISX:MDLA PT Medela Potentia Tbk ISX:MDLA
13 GF Score
Price Rp204.00
! 1 Warning Sign
View Full Analysis

What is PT Medela Potentia Tbk Research & Development?

PT Medela Potentia Tbk ISX:MDLA -0.97% 13 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:MDLA with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Medela Potentia Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Medela Potentia Tbk  (ISX:MDLA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Medela Potentia Tbk Research & Development Related Terms

PT Medela Potentia Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Medela Potentia Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medela Potentia Tbk Research & Development Chart

PT Medela Potentia Tbk Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

PT Medela Potentia Tbk Quarterly Data
Dec21 Dec22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:MDLA
13GF Score
PT Medela Potentia Tbk ISX:MDLA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Medela Potentia Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Medela Potentia Tbk (ISX:MDLA) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Medela Potentia Tbk and its competitors.
Is PT Medela Potentia Tbk's Research & Development too high?
PT Medela Potentia Tbk's current Research & Development is Rp0 Mil. Overall, PT Medela Potentia Tbk has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PT Medela Potentia Tbk's Research & Development compare to MCK and COR?
PT Medela Potentia Tbk's Research & Development of Rp0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Medela Potentia Tbk and its competitors. PT Medela Potentia Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medela Potentia Tbk stock overvalued right now?
PT Medela Potentia Tbk (ISX:MDLA) has a current Research & Development of Rp0 Mil. The current Research & Development is Rp0 Mil. PT Medela Potentia Tbk's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Medela Potentia Tbk (ISX:MDLA), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Medela Potentia Tbk Business Description

Address Jl. RS Fatmawati Kav. 33, Cilandak Barat, Jakarta Selatan, Jakarta, IDN, 12430
PT Medela Potentia Tbk is a healthcare-focused holding company engaged in pharmaceutical distribution, medical device manufacturing, and marketing services. It is engaged in the distribution and marketing of pharmaceutical products, health products, and medical devices. It also manufactures medical devices and implements web portals and digital platforms for commercial purposes through its subsidiaries. The Company manages three main operating segments, namely pharmaceutical products, healthcare products, and medical devices.
13GF Score

Get the complete analysis for ISX:MDLA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp204.00
Price